• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在有有限的已故供体活动的国家扩大活体肝移植供体库:巴基斯坦视角。

Expanding the living liver donor pool in countries having limited deceased donor activity: Pakistani perspective.

机构信息

Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences, Gambat, Sindh, Pakistan.

Shifa College of Medicine, Islamabad, Pakistan.

出版信息

Transpl Immunol. 2022 Dec;75:101683. doi: 10.1016/j.trim.2022.101683. Epub 2022 Aug 9.

DOI:10.1016/j.trim.2022.101683
PMID:35952941
Abstract

Over the last decades, liver transplantation (LT) has evolved into a life-saving procedure. Due to limited deceased donor activities in the eastern world, living donor liver transplantation (LDLT) had flourished tremendously in most Asian countries. Yet, these LDLT activities fall short of meeting the expected demands. Pakistan, a developing country, bears a major burden of liver diseases. Currently, only few centers offer LDLT services in the country. On the other hand, deceased donor liver transplantation (DDLT) activities have not started due to social, cultural, and religious beliefs. Various strategies can be adopted successfully to overcome the scarcity of live liver donors (LLDs) and to expand the donor pool, keeping in view donor safety and recipient outcome. These include consideration of LLDs with underlying clinical conditions like G6PD deficiency and Hepatitis B core positivity. Extended donor criteria can also be utilized and relaxation can be made in various donors' parameters including upper age and body mass index after approval from the multidisciplinary board. Also, left lobe grafts, grafts with various anatomical variations, and a low graft-to-recipient ratio can be considered in appropriate situations. ABO-incompatible LT and donor swapping at times may help in expanding the LLDs pool. Similarly, legislation is needed to allow live non-blood-related donors for organ donations. Finally, community education and awareness through various social media flat forms are needed to promote deceased organ donation.

摘要

在过去几十年中,肝移植(LT)已发展成为一种挽救生命的手术。由于东方世界已故供体活动有限,活体供体肝移植(LDLT)在大多数亚洲国家得到了迅猛发展。然而,这些 LDLT 活动仍无法满足预期需求。巴基斯坦是一个发展中国家,肝脏疾病负担沉重。目前,该国只有少数几个中心提供 LDLT 服务。另一方面,由于社会、文化和宗教信仰的原因,已故供体肝移植(DDLT)活动尚未开始。可以成功采用各种策略来克服活体肝供体(LLD)的短缺问题,并扩大供体库,同时确保供体安全和受者的治疗效果。这些策略包括考虑有潜在临床疾病(如 G6PD 缺乏症和乙型肝炎核心抗体阳性)的 LLD。也可以利用扩展的供体标准,并在多学科委员会批准后,放宽包括年龄上限和体重指数在内的各种供体参数。此外,在适当情况下可以考虑使用左叶移植物、具有各种解剖变异的移植物和低移植物与受体比例。ABO 不相容的 LT 和供体交换有时可以帮助扩大 LLD 池。同样,需要立法允许活体非血缘关系供体进行器官捐赠。最后,需要通过各种社交媒体平台开展社区教育和宣传,以促进已故器官捐赠。

相似文献

1
Expanding the living liver donor pool in countries having limited deceased donor activity: Pakistani perspective.在有有限的已故供体活动的国家扩大活体肝移植供体库:巴基斯坦视角。
Transpl Immunol. 2022 Dec;75:101683. doi: 10.1016/j.trim.2022.101683. Epub 2022 Aug 9.
2
Obstacles to the deceased donor transplantation in Pakistan.巴基斯坦器官捐献移植的障碍。
BMJ Open Gastroenterol. 2023 May;10(1). doi: 10.1136/bmjgast-2022-001101.
3
Why does living donor liver transplantation flourish in Asia?为什么活体供肝移植在亚洲如此盛行?
Nat Rev Gastroenterol Hepatol. 2013 Dec;10(12):746-51. doi: 10.1038/nrgastro.2013.194. Epub 2013 Oct 8.
4
Does living donation have advantages over deceased donation in liver transplantation?在肝移植中,活体捐赠相对于尸体捐赠有优势吗?
J Gastroenterol Hepatol. 2010 Oct;25(10):1598-603. doi: 10.1111/j.1440-1746.2010.06418.x.
5
Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.ABO 不相容肝移植后的临床结局:系统评价和荟萃分析。
Transpl Immunol. 2021 Dec;69:101476. doi: 10.1016/j.trim.2021.101476. Epub 2021 Oct 1.
6
Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.继发不可切除肝肿瘤:单中心活体供肝与尸体供肝肝移植病例系列。
Hepatobiliary Pancreat Dis Int. 2019 Oct;18(5):412-422. doi: 10.1016/j.hbpd.2019.08.005. Epub 2019 Aug 25.
7
Current status of liver transplantation in Asia.亚洲的肝移植现状。
Int J Surg. 2020 Oct;82S:4-8. doi: 10.1016/j.ijsu.2020.05.071. Epub 2020 Jun 11.
8
Living donor liver transplantation for hepatocellular carcinoma.肝细胞癌的活体供肝肝移植
Recent Results Cancer Res. 2013;190:165-79. doi: 10.1007/978-3-642-16037-0_11.
9
Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation.在脑死亡供体和活体供体肝移植中具有可比的短期和长期结果。
Hepatol Int. 2017 Nov;11(6):517-522. doi: 10.1007/s12072-017-9821-2. Epub 2017 Sep 21.
10
A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients.成人活体肝移植的全面治疗:手术技术综述及扩大患者适应症的当前挑战
Am J Transplant. 2015 Jan;15(1):17-38. doi: 10.1111/ajt.12907. Epub 2014 Oct 30.

引用本文的文献

1
Post-transplant hepatitis B virus reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-centre retrospective cohort study in China.移植后乙型肝炎病毒再激活影响乙型肝炎相关肝细胞癌患者的预后:中国的一项双中心回顾性队列研究。
Int J Surg. 2024 Apr 1;110(4):2263-2274. doi: 10.1097/JS9.0000000000001141.
2
Donor's ability to comprehend and carefully assess the benefits and risks of donation in living donor liver transplantation: a Pakistani perspective - a short communication.活体肝移植中供体理解并仔细评估捐赠利弊的能力:巴基斯坦视角——一篇简短通讯
Ann Med Surg (Lond). 2023 Jul 31;85(9):4646-4648. doi: 10.1097/MS9.0000000000001121. eCollection 2023 Sep.
3
Obstacles to the deceased donor transplantation in Pakistan.
巴基斯坦器官捐献移植的障碍。
BMJ Open Gastroenterol. 2023 May;10(1). doi: 10.1136/bmjgast-2022-001101.
4
Hepatitis E infection in chronic liver disease patients causing acute on chronic liver failure: Vaccination is need of the hour.慢性肝病患者感染戊型肝炎导致慢加急性肝衰竭:当下亟需接种疫苗。
BMJ Open Gastroenterol. 2022 Dec;9(1). doi: 10.1136/bmjgast-2022-001051.
5
Evolving liver transplantation in Pakistan: Future challenges.巴基斯坦肝脏移植的发展:未来挑战
Ann Med Surg (Lond). 2022 Sep 17;82:104669. doi: 10.1016/j.amsu.2022.104669. eCollection 2022 Oct.
6
ABO incompatible living donor liver transplant with antibody titer of 1:4: First case report from Pakistan.抗体滴度为1:4的ABO血型不相容活体肝移植:巴基斯坦首例病例报告
Ann Med Surg (Lond). 2022 Aug 19;81:104463. doi: 10.1016/j.amsu.2022.104463. eCollection 2022 Sep.